LICN Valuation
Lichen China Ltd
$
3.360
- Overview
- Forecast
- Valuation
LICN Relative Valuation
LICN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, LICN is overvalued; if below, it's undervalued.
Historical Valuation
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
0.01
P/B
Median3y
0.71
Median5y
0.71
91.85
FCF Yield
Median3y
3.33
Median5y
3.33
Competitors Valuation Multiple
The average P/S ratio for LICN's competitors is 0.02, providing a benchmark for relative valuation. Lichen China Ltd Corp (LICN) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appearsunsustainable.
People Also Watch
MFA
MFA Financial Inc
9.580
USD
-5.43%
HEPS
D Market Elektronik Hizmetler ve Ticaret AS
2.580
USD
-6.18%
CSR
Centerspace
60.220
USD
-2.71%
GYRE
Gyre Therapeutics Inc
6.920
USD
+1.76%
PCRX
Pacira Biosciences Inc
23.100
USD
-4.90%
EVGO
EVgo Inc
2.570
USD
+0.78%
DCO
Ducommun Inc
54.260
USD
-3.04%
VMEO
Vimeo Inc
4.750
USD
-2.86%
ARR
ARMOUR Residential REIT Inc
15.070
USD
-8.11%
UUUU
Energy Fuels Inc
3.450
USD
-4.96%
FAQ
Is Lichen China Ltd (LICN) currently overvalued or undervalued?
Lichen China Ltd(LICN) is now in theFairzone, suggesting that its currentforward PSratio of0.00is consideredFairlycompared with the five-year average of0.00.The fair price of Lichen China Ltd(LICN)is betweentoaccording to relative valuation methord.
What is Lichen China Ltd (LICN) fair value?
How does LICN's valuation metrics compare to the industry average?
What is the current P/B ratio for Lichen China Ltd (LICN) as of Apr 07 2025?
What is the current FCF Yield for Lichen China Ltd (LICN) as of Apr 07 2025?
What is the current Forward P/E ratio for Lichen China Ltd (LICN) as of Apr 07 2025?